Tag: biosimilars vs generics
Biosimilars are billed differently than generics under Medicare Part B. Each has its own HCPCS code and payment rate based on its ASP plus 6% of the reference product’s price. This system encourages biosimilar entry but doesn’t strongly incentivize switching. Learn how billing works and why adoption remains low in the U.S.
Categories
Medications
Archives
Recent-posts
9 Alternatives to Levothyroxine
Apr, 7 2025
Age-Related Macular Degeneration: How Central Vision Loss Happens and How Anti-VEGF Treatments Help
Jan, 12 2026
Coupon codes for online drug store rx2world.com
Oct, 27 2023
Inactive Ingredients in Generic Medications: What You Need to Know
Nov, 29 2025
Best Digital Tools for Patient Education: Apps and E-Learning in 2025
Dec, 27 2025